Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(15%)

Phase Distribution

Ph phase_1
1
8%
Ph not_applicable
11
85%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
N/ANon-phased studies
11(91.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

72.7%

8 of 11 finished

Non-Completion Rate

27.3%

3 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(8)
Terminated(3)
Other(2)

Detailed Status

Completed8
unknown2
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
80.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (8.3%)
N/A11 (91.7%)

Trials by Status

completed862%
unknown215%
withdrawn18%
terminated215%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
13